Orthofix Medical Inc. Foreign Currency Transaction Gain (Loss), before Tax
Orthofix Medical Inc. (OFIX) reported Foreign Currency Transaction Gain (Loss), before Tax of $746.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-05
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $746.00K.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $900.00K.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $314.00K, a 89.97% decline year-over-year.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $571.00K.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$2.91M, a 166.21% decline from fiscal 2024.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was $4.39M.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$1.58M, a 148.04% decline from fiscal 2022.
- Orthofix Medical Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was $3.29M, a 17.33% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $746.00K 10-Q · filed 2026-08-05 | $1.65M 10-Q · filed 2026-08-05 | $1.96M derived: sum of 3 quarters · filed 2026-08-05 | $2.53M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $900.00K 10-Q · filed 2026-05-05 | $1.21M derived: sum of 2 quarters · filed 2026-05-05 | $1.78M derived: sum of 3 quarters · filed 2026-05-05 | -$966.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $885.00K derived: sum of 2 quarters · filed 2026-02-24 | -$1.87M derived: sum of 3 quarters · filed 2026-08-05 | -$2.91M 10-K · filed 2026-02-24 |
| 2025-09-30 | $571.00K 10-Q · filed 2025-11-04 | -$2.18M derived: sum of 2 quarters · filed 2026-08-05 | -$3.22M 10-Q · filed 2025-11-04 | -$92.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.75M 10-Q · filed 2026-08-05 | -$3.79M 10-Q · filed 2026-08-05 | -$663.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.84M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.04M 10-Q · filed 2026-05-05 | $2.09M derived: sum of 2 quarters · filed 2026-05-05 | $912.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.76M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.96M derived: sum of 2 quarters · filed 2026-02-24 | $2.81M derived: sum of 3 quarters · filed 2026-02-24 | $4.39M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.18M 10-Q · filed 2025-11-04 | -$325.00K derived: sum of 2 quarters · filed 2025-11-04 | $1.26M 10-Q · filed 2025-11-04 | -$1.38M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $851.00K 10-Q · filed 2025-08-05 | $2.44M 10-Q · filed 2025-08-05 | -$199.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.71M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $1.59M 10-Q · filed 2025-05-06 | -$1.05M derived: sum of 2 quarters · filed 2026-02-24 | $859.00K derived: sum of 3 quarters · filed 2026-02-24 | $590.00K derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | -$2.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$729.00K derived: sum of 2 quarters · filed 2026-02-24 | -$998.00K derived: sum of 3 quarters · filed 2026-02-24 | -$1.58M 10-K · filed 2026-02-24 |
| 2023-09-30 | $1.91M 10-Q · filed 2024-11-07 | $1.64M derived: sum of 2 quarters · filed 2024-11-07 | $1.06M 10-Q · filed 2024-11-07 | -$3.14M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$269.00K 10-Q · filed 2024-08-06 | -$852.00K 10-Q · filed 2024-08-06 | -$5.05M derived: sum of 3 quarters · filed 2025-02-25 | -$1.79M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$583.00K 10-Q · filed 2024-05-07 | -$4.78M derived: sum of 2 quarters · filed 2025-02-25 | -$1.52M derived: sum of 3 quarters · filed 2025-02-25 | $1.47M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$942.00K derived: sum of 2 quarters · filed 2025-02-25 | $2.05M derived: sum of 3 quarters · filed 2025-02-25 | $3.29M 10-K · filed 2025-02-25 |
| 2022-09-30 | $3.25M 10-Q · filed 2023-11-08 | $6.24M derived: sum of 2 quarters · filed 2023-11-08 | $7.49M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $2.99M 10-Q · filed 2023-08-08 | $4.23M 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $1.24M 10-Q · filed 2023-05-09 | |||
| 2021-12-31 | $3.98M 10-K · filed 2024-03-05 | |||
| 2013-03-31 | $623.00K 10-Q/A · filed 2014-03-24 | |||
| 2012-03-31 | -$470.00K 10-Q/A · filed 2014-03-24 | |||
| 2011-12-31 | -$1.60M 10-K · filed 2012-02-29 | |||
| 2010-12-31 | -$100.00K 10-K · filed 2012-02-29 | |||
| 2009-12-31 | -$500.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |